 |
Partner 1Institute of Virology and
Immunoprophylaxis (IVI) FDEA/FVO: Federal
Veterinary Office of the Federal Department of
Economic Affairs, Institute of Virology and
Immunoprophylaxis is a Biosafety Level 4 facility
with BSL2 and BSL3 laboratories and BSL3+ animal
accommodation. The Research Department provides
expertise on immunological correlates,
particularly to in vitro alternatives to animal
experimentation. Therein, the Immunology Group
has an established reputation in dendritic cell
(DC) biology, modulation of DC responses
following interaction with vaccines, and
targeting vaccines to DC. The Virology Group has
an established reputation in viral RNA biology,
providing experience on RNA vaccines and signal
transduction pathways in innate responses to
virus infection.
|
 |
Partner 2Crucell is an established
influenza vaccine manufacturer and is known for
the development of novel vaccine technology.
Crucell will provide influenza vaccine and
adjuvant expertise by the GMP manufacturing of
vaccine formulations for preclinical and clinical
testing.
|
 |
Partner 3National Institute for Biological
Standards and Control, (NIBSC) will provide
expertise in recombinant virus generation,
reagent preparation, in vivo immunological
studies and serological analyses. Drs Wood and
Robertson are internationally renowned experts in
these areas.
|
 |
Partner 4Retroscreen Virology Ltd is
Europe's leading contract Virology research
company. The work we conduct is dedicated to
creating the next generation of Antivirals and
Vaccines in the field of biomedical research. Our
research includes both Pre-Clinical and Clinical
projects.
|
 |
Partner 5University of Bergen, The
Influenza Centre, The Gade Institute, has its
expertise from many facets of the influenza
field, in later years especially from studies of
the kinetics and quality of the B- and T-cell
response, herein memory and mucosal elements,
following influenza vaccination. The Centre has
many years experience in designing and executing
pre-clinical and clinical trials of influenza
vaccines.
|
 |
Partner 6Health Protection Agency, Respiratory & Neurological Virus
Laboratory, Respiratory Unit HPA is an
independent body that protects the health and
well-being of the population. The Agency plays a
critical role in protecting people from
infectious diseases and in preventing harm when
hazards involving chemicals, poisons or radiation
occur.
|
 |
Partner 7Istituto Superiore di Sanità
(ISS), Department of Infectious,
Immune-mediated and Parasitic Diseases. The
National Influenza Centre (NIC) will provide
expertise on preclinical and clinical evaluation
of serological responses to pandemic influenza
vaccines. The group has long-lasting experience
in serosurveys aimed at detecting antibodies to
human as well as avian influenza strains in human
sera using both conventional and recently
developed methods.
|
 |
Partner 8Helmholtz, Zentrum für
infektionsforschung studies and investigates
pathogens which are medically relevant or can be
used as models for researching infection
mechanisms.
|
 |
Partner 9SCIPROM Scientific Project
Management is a Swiss company that supports
researchers in European and National projects,
networks and research consortia. SCIPROM helps
with or takes over project construction,
submission, negotiation, execution and
management.
|